Top

Published in:

01-02-2006 | Case Report

Topiramate Therapy for Symptomatic Trigeminal Neuralgia

Authors: A. Siniscalchi, Dr L. Gallelli, D. Scornaienghi, F. Mancuso, G. De Sarro

Published in: Clinical Drug Investigation | Issue 2/2006

Excerpt

Trigeminal neuralgia is a paroxysmal form of facial pain usually affecting the second and third divisions of the trigeminal nerve, and which occurs in 1.9–4.4% of patients affected by multiple sclerosis.[1] …

Crayton H, Heyman RA, Rosmann HS. A multimodal approach to managing the symptoms of multiple sclerosis. Neurology 2004; 63: S12–8PubMedCrossRef

Tomson T, Tybring G, Bertilsson L, et al. Carbamazepine therapy in trigeminal neuralgia: clinical effects in relation to plasma concentration. Arch Neurol 1980; 37: 699–703PubMedCrossRef

Tomson T, Bertilsson L. Potent therapeutic effect of carbamazepine-10,11-epoxide in trigeminal neuralgia. Arch Neurol 1984; 41: 588–601

Cheshire WP. Trigeminal neuralgia: a guide to drug choice. CNS Drugs 1997; 7: 98–110CrossRef

Sindrup SH, Jensen TS. Pharmacotherapy of trigeminal neuralgia. Clin J Pain 2002; 18: 22–7PubMedCrossRef

Peiris JB, Perera GLS, Devendra SV, et al. Sodium valproate in trigeminal neuralgia [letter]. Med J Aust 1980; 2: 278PubMed

Desai N, Shah K, Gandhi I. Baclofen sodium valproate combination in carbamazepine resistant trigeminal neuralgia: a double blind clinical trial. Cephalalgia 1991; 11Suppl. 11: 321–2

Zakrzewska JM, Chaudhry Z, Nurmikko TJ, et al. Lamotrigine (Lamictal) in refractory trigeminal neuralgia: results from a double-blind placebo controlled crossover trial. Pain 1997; 73: 223–30PubMedCrossRef

Khan OA. Gabapentin relieves trigeminal neuralgia in multiple sclerosis patients. Neurology 1998; 51: 611–4PubMedCrossRef

10.

Zvartau-Hind M, Din MU, Gilani A, et al. Topiramate relieves refractory trigeminal neuralgia in MS patients. Neurology 2000; 55: 1587–8PubMedCrossRef

11.

Spina E, Perugi G. Antiepileptic drugs: indications other than epilepsy. Epileptic Disord 2004; 6: 57–65PubMed

12.

Jensen MP, Turner JA, Romano JM. What is the maximum number of levels needed in pain intensity measurement? Pain 1994; 58: 387–92PubMedCrossRef

13.

Berthier F, Potel G, Leconte P, et al. Comparative study of methods of measuring acute pain intensity in an ED. Am J Emerg Med 1998; 16: 132–6PubMedCrossRef

14.

Perucca E. An introduction to antiepileptic drugs. Epilepsia 2005; 46: 31–7PubMedCrossRef

15.

Gilron I, Booher SL, Rowan JS, et al. Topiramate in trigeminal neuralgia: a randomized, placebo-controlled multiple crossover pilot study. Clin Neuropharmacol 2001; 24(2): 109–12PubMedCrossRef

16.

Burchiel KJ. Abnormal impulse generation in focally demyelinated trigeminal roots. J Neurosurg 1980; 53: 674–83PubMedCrossRef

17.

Sakurai M, Kanazawa I. Positive symptoms in multiple sclerosis: their treatment with sodium channel blockers, lidocaine and mexiletine. J Neurol Sci 1999; 15: 162–8CrossRef

18.

Solaro C, Lunardi GL, Capello E, et al. An open-label trial of gabapentin treatment of paroxysmal symptoms in multiple sclerosis patients. Neurology 1998; 51: 609–11PubMedCrossRef

19.

Russo E, Constanti A, Ferreri G, et al. Nifedipine affects the anticonvulsant activity of topiramate in various animal models of epilepsy. Neuropharmacology 2004; 46: 865–78PubMedCrossRef

20.

Tidwell A, Swims M. Review of the newer antiepileptic drugs. Am J Manag Care 2003; 9: 253–76PubMed

21.

Nieto-Barrera M. Characteristics and indications of topiramate. Rev Neurol 2002; 35Suppl. 1: S88–95PubMed

22.

Bialer M, Doose DR, Murthy B, et al. Pharmacokinetic interactions of topiramate. Clin Pharmacokinet 2004; 43: 763–80PubMedCrossRef

Title: Topiramate Therapy for Symptomatic Trigeminal Neuralgia
Authors: A. Siniscalchi
Dr L. Gallelli
D. Scornaienghi
F. Mancuso
G. De Sarro
Publication date: 01-02-2006
Publisher: Springer International Publishing
Published in: Clinical Drug Investigation / Issue 2/2006
Print ISSN: 1173-2563
Electronic ISSN: 1179-1918
DOI: https://doi.org/10.2165/00044011-200626020-00006

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Topiramate Therapy for Symptomatic Trigeminal Neuralgia

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 2/2006

Healthcare Use, Social Burden and Costs of Children With and Without ADHD in Flanders, Belgium

Alendronic Acid Produces Greater Effects than Risedronic Acid on Bone Density and Turnover in Postmenopausal Women with Osteoporosis

Linguistic Adaptation and Validation of the Spanish Version of the Benign Prostatic Hyperplasia-Patient Impact Measure (BPH-PIM®)

Efficacy and Safety of 24 Weeks of Therapy with Bendroflumethiazide 1.25 mg/day or 2.5 mg/day and Potassium Chloride Compared with Enalapril 10 mg/day and Amlodipine 5 mg/day in Patients with Mild to Moderate Primary Hypertension

Methotrexate and Hepatic Toxicity in Rheumatoid Arthritis and Psoriatic Arthritis